June 2018 Question of the Month
Do you feel that disclosing the list price of prescription drugs during DTC ads will decrease patient demand for certain products?
Yes: 14.3%
No: 85.7%
Poll Results
November 2019 Question of the Month
The new Fair and Accurate Medicaid Pricing Act excludes Authorized Generics (AG) from AMP calculations for brand manufacturers, likely increasing their AMP prices and subsequent rebates. How will this change effect brand manufacturers decision to launch an AG or not?
Brand manufacturer will reconsider when to launch the AG and only launch after an ANDA is approved: 100%
Brand manufacturer will launch the AG before the ANDA is introduced in the market: 0%
The Act will not impact brand manufacturers’ decisions to launch AGs: 0%
Brand manufacturers will not launch AG’s any longer: 0%
October 2019 Question of the Month
Biosimilars have gotten off to a slow start in the marketplace. What change will most dramatically affect the adoption rate?
PBM Formulary and coverage decisions: 83%
New Legislation: 17%
HHS/CMS Policy Changes: 0%
September 2019 Question of the Month
Who will be the slowest to adopt the electronic real-time benefit check?
Physicians: 53.8%
PBMs: 30.8%
EMRs: 15.4%
Surescripts: 0%
Contact
968 Perry Highway
Pittsburgh, PA 15237
Get Directions »
Phone: (412) 635-4650
Follow/Subscribe:
